China · Delayed Price · Currency is CNY Winner Medical Statistics
Total Valuation
Winner Medical has a market cap or net worth of CNY 21.92 billion. The enterprise value is 21.18 billion.
| Market Cap | 21.92B |
| Enterprise Value | 21.18B |
Important Dates
The next estimated earnings date is Friday, October 24, 2025.
| Earnings Date | Oct 24, 2025 |
| Ex-Dividend Date | Sep 3, 2025 |
Share Statistics
Winner Medical has 582.33 million shares outstanding. The number of shares has decreased by -1.32% in one year.
| Current Share Class | 582.33M |
| Shares Outstanding | 582.33M |
| Shares Change (YoY) | -1.32% |
| Shares Change (QoQ) | +1.47% |
| Owned by Insiders (%) | 70.43% |
| Owned by Institutions (%) | 7.81% |
| Float | 159.40M |
Valuation Ratios
The trailing PE ratio is 27.32 and the forward PE ratio is 21.05.
| PE Ratio | 27.32 |
| Forward PE | 21.05 |
| PS Ratio | 2.14 |
| PB Ratio | 1.79 |
| P/TBV Ratio | 2.38 |
| P/FCF Ratio | 34.06 |
| P/OCF Ratio | 15.52 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.11, with an EV/FCF ratio of 32.90.
| EV / Earnings | 26.36 |
| EV / Sales | 2.07 |
| EV / EBITDA | 13.11 |
| EV / EBIT | 21.00 |
| EV / FCF | 32.90 |
Financial Position
The company has a current ratio of 1.68, with a Debt / Equity ratio of 0.20.
| Current Ratio | 1.68 |
| Quick Ratio | 1.20 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 1.55 |
| Debt / FCF | 3.90 |
| Interest Coverage | 15.99 |
Financial Efficiency
Return on equity (ROE) is 7.02% and return on invested capital (ROIC) is 4.40%.
| Return on Equity (ROE) | 7.02% |
| Return on Assets (ROA) | 3.64% |
| Return on Invested Capital (ROIC) | 4.40% |
| Return on Capital Employed (ROCE) | 7.48% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 15,642 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 3.24 |
Taxes
In the past 12 months, Winner Medical has paid 227.93 million in taxes.
| Income Tax | 227.93M |
| Effective Tax Rate | 21.09% |
Stock Price Statistics
The stock price has increased by +30.57% in the last 52 weeks. The beta is 0.36, so Winner Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | +30.57% |
| 50-Day Moving Average | 40.38 |
| 200-Day Moving Average | 42.41 |
| Relative Strength Index (RSI) | 32.57 |
| Average Volume (20 Days) | 6,164,955 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Winner Medical had revenue of CNY 10.24 billion and earned 803.23 million in profits. Earnings per share was 1.38.
| Revenue | 10.24B |
| Gross Profit | 4.73B |
| Operating Income | 1.01B |
| Pretax Income | 1.08B |
| Net Income | 803.23M |
| EBITDA | 1.39B |
| EBIT | 1.01B |
| Earnings Per Share (EPS) | 1.38 |
Balance Sheet
The company has 4.00 billion in cash and 2.51 billion in debt, giving a net cash position of 1.50 billion or 2.57 per share.
| Cash & Cash Equivalents | 4.00B |
| Total Debt | 2.51B |
| Net Cash | 1.50B |
| Net Cash Per Share | 2.57 |
| Equity (Book Value) | 12.28B |
| Book Value Per Share | 19.64 |
| Working Capital | 3.10B |
Cash Flow
In the last 12 months, operating cash flow was 1.41 billion and capital expenditures -768.77 million, giving a free cash flow of 643.58 million.
| Operating Cash Flow | 1.41B |
| Capital Expenditures | -768.77M |
| Free Cash Flow | 643.58M |
| FCF Per Share | 1.11 |
Margins
Gross margin is 46.18%, with operating and profit margins of 9.85% and 7.84%.
| Gross Margin | 46.18% |
| Operating Margin | 9.85% |
| Pretax Margin | 10.55% |
| Profit Margin | 7.84% |
| EBITDA Margin | 13.54% |
| EBIT Margin | 9.85% |
| FCF Margin | 6.28% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 1.33%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 1.33% |
| Dividend Growth (YoY) | -22.22% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 67.26% |
| Buyback Yield | 1.32% |
| Shareholder Yield | 2.65% |
| Earnings Yield | 3.66% |
| FCF Yield | 2.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 2, 2023. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 2, 2023 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
Winner Medical has an Altman Z-Score of 3.78 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.78 |
| Piotroski F-Score | 6 |